Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 180

1.

Soyasaponin Ag inhibits α‑MSH‑induced melanogenesis in B16F10 melanoma cells via the downregulation of TRP‑2.

Yang SH, Tsatsakis AM, Tzanakakis G, Kim HS, Le B, Sifaki M, Spandidos DA, Tsukamoto C, Golokhvast KS, Izotov BN, Chung G.

Int J Mol Med. 2017 Sep;40(3):631-636. doi: 10.3892/ijmm.2017.3061. Epub 2017 Jul 10.

2.

The slaty (slt/Dct(slt) ) allele decreases the content of eumelanin, but not pheomelanin in the mouse hair.

Hirobe T, Ito S, Wakamatsu K.

Pigment Cell Melanoma Res. 2016 Jan;29(1):110-2. doi: 10.1111/pcmr.12427. Epub 2015 Nov 18. No abstract available.

PMID:
26451690
3.

Controlled insertional mutagenesis using a LINE-1 (ORFeus) gene-trap mouse model.

O'Donnell KA, An W, Schrum CT, Wheelan SJ, Boeke JD.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):E2706-13. doi: 10.1073/pnas.1302504110. Epub 2013 Jul 1.

4.

Cytomegalovirus-based cancer vaccines expressing TRP2 induce rejection of melanoma in mice.

Xu G, Smith T, Grey F, Hill AB.

Biochem Biophys Res Commun. 2013 Jul 26;437(2):287-91. doi: 10.1016/j.bbrc.2013.06.068. Epub 2013 Jun 27.

5.

Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.

You S, Cho YH, Byun JS, Shin EC.

Clin Exp Immunol. 2013 Oct;174(1):38-44. doi: 10.1111/cei.12146.

6.

I-SceI-mediated double-strand break does not increase the frequency of homologous recombination at the Dct locus in mouse embryonic stem cells.

Fenina M, Simon-Chazottes D, Vandormael-Pournin S, Soueid J, Langa F, Cohen-Tannoudji M, Bernard BA, Panthier JJ.

PLoS One. 2012;7(6):e39895. doi: 10.1371/journal.pone.0039895. Epub 2012 Jun 26.

7.

Functional characterization of melanocyte stem cells in hair follicles.

Nishikawa-Torikai S, Osawa M, Nishikawa S.

J Invest Dermatol. 2011 Dec;131(12):2358-67. doi: 10.1038/jid.2011.195. Epub 2011 Jul 14.

8.

Purification and N-glycosylation analysis of melanoma antigen dopachrome tautomerase.

Vavricka CJ, Ray KW, Christensen BM, Li J.

Protein J. 2010 Apr;29(3):204-12. doi: 10.1007/s10930-010-9241-9.

PMID:
20386969
9.
10.
11.
12.
13.

The slaty mutation affects eumelanin and pheomelanin synthesis in mouse melanocytes.

Hirobe T, Wakamatsu K, Ito S, Kawa Y, Soma Y, Mizoguchi M.

Eur J Cell Biol. 2006 Jun;85(6):537-49. Epub 2006 Apr 3.

PMID:
16584806
14.

Mutations in dopachrome tautomerase (Dct) affect eumelanin/pheomelanin synthesis, but do not affect intracellular trafficking of the mutant protein.

Costin GE, Valencia JC, Wakamatsu K, Ito S, Solano F, Milac AL, Vieira WD, Yamaguchi Y, Rouzaud F, Petrescu AJ, Lamoreux ML, Hearing VJ.

Biochem J. 2005 Oct 15;391(Pt 2):249-59.

15.

The inhibition of early N-glycan processing targets TRP-2 to degradation in B16 melanoma cells.

Negroiu G, Dwek RA, Petrescu SM.

J Biol Chem. 2003 Jul 18;278(29):27035-42. Epub 2003 Apr 28.

16.
17.

Syntenic assignment of dopamine tautomerase (DCT) to bovine chromosome 12.

Sun HS, Womack JE, Kirkpatrick BW.

Anim Genet. 1996 Dec;27(6):421-2.

PMID:
9022157
18.

Molecular mechanism for catalysis by a new zinc-enzyme, dopachrome tautomerase.

Solano F, Jiménez-Cervantes C, Martínez-Liarte JH, García-Borrón JC, Jara JR, Lozano JA.

Biochem J. 1996 Jan 15;313 ( Pt 2):447-53.

20.

Functional analysis of the slaty gene product (TRP2) as dopachrome tautomerase and the effect of a point mutation on its catalytic function.

Kroumpouzos G, Urabe K, Kobayashi T, Sakai C, Hearing VJ.

Biochem Biophys Res Commun. 1994 Jul 29;202(2):1060-8.

PMID:
8048919

Supplemental Content

Support Center